|
CA2431425A1
|
|
Epas1 gene transfer to improve cell therapy
|
|
WO03025171A2
|
|
Modulation of retinoic acid receptor gene expression and therapeutic uses thereof
|
|
AU2002322911A1
|
|
Use of alphacp1, alphacp2, and hur for modulating gene expression and inducing angiogenesis
|
|
WO03003923A2
|
|
Method and system for endovascular radiation detection
|
|
US7608698B2
|
|
Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
|
|
EP1842856A2
|
|
Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
|
|
WO02065946A1
|
|
Apparatus for loading a therapeutic agent onto an endovascular device
|
|
WO02065945A1
|
|
Use of occlusion device for the local delivery of biologically active dna therapeutic compounds for treating aneurysms and use thereof
|
|
WO02066092A2
|
|
Drug eluting device for treating vascular diseases
|
|
WO0239898A2
|
|
Radiation detection catheter
|
|
CA2387477A1
|
|
Radioactively coated device and method of making same for preventing restenosis
|
|
US6626928B1
|
|
Occlusion device for treating aneurysm and use therefor
|
|
WO0100821A1
|
|
Antisense oligonucleotide modulating cyclin e gene expression and therapeutic uses thereof
|
|
US5821354A
|
|
Radiolabeled DNA oligonucleotide and method of preparation
|
